Cerevel Therapeutics
CERE
#1976
Rank
S$10.97 B
Marketcap
$60.23
Share price
0.00%
Change (1 day)
105.14%
Change (1 year)

Cerevel Therapeutics (CERE) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : S$0.75 Billion

According to Cerevel Therapeutics's latest financial reports the company's total liabilities are S$0.75 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cerevel Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.75 B12.99%
2022-12-31S$0.66 B346.89%
2021-12-31S$0.14 B85.35%
2020-12-31S$80.37 M38.7%
2019-12-31S$57.94 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$40.50 B 5,271.76%๐Ÿ‡บ๐Ÿ‡ธ USA
S$54.32 B 7,103.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.15 B 2,174.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.32 B 1,932.20%๐Ÿ‡บ๐Ÿ‡ธ USA